Piperidine → HCID 86717258, compound
Reaction equation
[O:1]1[C:5]2[CH:6]=[CH:7][C:8]([C:10]3[CH2:11][C@@H:12]4[N:18]([CH:19]=3)[C:17](=[O:20])[C:16]3[CH:21]=[C:22]([O:83][CH3:84])[C:23]([O:25][CH2:26][CH2:27][CH2:28][O:29][C:30]5[C:80]([O:81][CH3:82])=[CH:79][C:33]6[C:34](=[O:78])[N:35]7[CH:41]=[C:40]([C:42]8[CH:47]=[CH:46][C:45]([NH:48][C:49](=[O:77])[C@@H:50]([NH:52][C:53](=[O:76])[C@@H:54]([NH:58]C(=O)OCC9C%10C=CC=CC=%10C%10C9=CC=CC=%10)[CH:55]([CH3:57])[CH3:56])[CH3:51])=[CH:44][CH:43]=8)[CH2:39][C@H:36]7[CH:37]=[N:38][C:32]=6[CH:31]=5)=[CH:24][C:15]=3[N:14]=[CH:13]4)=[CH:9][C:4]=2[O:3][CH2:2]1.N1CCCCC1>CN(C=O)C>[NH2:58][C@@H:54]([CH:55]([CH3:57])[CH3:56])[C:53]([NH:52][C@@H:50]([CH3:51])[C:49]([NH:48][C:45]1[CH:44]=[CH:43][C:42]([C:40]2[CH2:39][C@@H:36]3[N:35]([CH:41]=2)[C:34](=[O:78])[C:33]2[CH:79]=[C:80]([O:81][CH3:82])[C:30]([O:29][CH2:28][CH2:27][CH2:26][O:25][C:23]4[C:22]([O:83][CH3:84])=[CH:21][C:16]5[C:17](=[O:20])[N:18]6[CH:19]=[C:10]([C:8]7[CH:7]=[CH:6][C:5]8[O:1][CH2:2][O:3][C:4]=8[CH:9]=7)[CH2:11][C@H:12]6[CH:13]=[N:14][C:15]=5[CH:24]=4)=[CH:31][C:32]=2[N:38]=[CH:37]3)=[CH:47][CH:46]=1)=[O:77])=[O:76]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
The imine 35 (82 mg, 0.07 mmol, 1 equiv.) was dissolved in DMF (1 mL) before piperidine (0.2 mL, 2 mmol, excess) was added slowly. This solution was left to stir at room temperature for 20 minutes until LC/MS analysis showed complete consumption of starting material. The reaction mixture was diluted with CH2Cl2 (50 mL), washed with water (50 mL×4), dried with MgSO4, filtered and the solvent removed in vacuo. The product 33 was used without further purification in the next step. LC/MS (1.15 min (ES+) m/z (relative intensity) 910.60 ([M+H]+, 58).
Workup
- additionwas added slowly
- waitThis solution was left
- customconsumption of starting material
- additionThe reaction mixture was diluted with CH2Cl2 (50 mL)
- washwashed with water (50 mL×4)
- dry with materialdried with MgSO4
- filtrationfiltered
- customthe solvent removed in vacuo
- customThe product 33 was used without further purification in the next step
- custom1.15 min (ES+) m/z (relative intensity) 910.60 ([M+H]+, 58)
Sources & evidence
- ORD record
- ord-9f0cb3ba07c447bbae35ab09b9a768f2
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09415117B2
Reaction notes
Loading…